Navigation Links
National Stroke Association Teams With Clinical Trial Matching Service CureLauncher
Date:7/23/2013

Bloomfrield Hills, MI (PRWEB) July 23, 2013

Michigan-based CureLauncher (http://www.curelauncher.com), developer of a patent-pending and proprietary clinical trial matching service, today announced an exclusive partnership with the National Stroke Association—a leading educational, prevention and advocacy group for individuals and their families and health care professionals confronting health issues related to strokes.

National Stroke Association members and visitors will be directed to http://www.curelauncher.com, where specially trained relationship managers help individuals find a clinical trial that may offer access to a new diagnostic test, treatment or rehabilitative approach.

“We are thrilled to partner with CureLauncher,” said Jim Baranski, National Stroke Association CEO. “Together, we can make progress in preventing, treating and understanding this challenging condition that impacts so many American families. In particular, clinical medical research is bringing us new diagnostic techniques to identify individuals at risk for stroke, as well as life strategies and other approaches to prevention.”

The power of clinical trials. Nearly 200 million Americans have a chronic disease such as diabetes, heart disease, asthma or cancer. Less than five percent of them know where to find new treatments available in clinical trials according to the Center for Information & Study on Clinical Research Participation (CISCRP). Yet, some of America’s best medical care is available through these clinical trials.

"CureLauncher redefines the approach to clinical trials by putting people and their families first," said David Fuehrer, CureLauncher President, who is also a two-time cancer survivor and active speaker and volunteer for various support communities.

“We are excited to collaborate with the National Stroke Association. We want to help them in their quest to prevent or alleviate what is now the nation’s fourth leading cause of death,” Fuehrer added.

About National Stroke Association:
The National Stroke Association was formed in 1984 to fill a void as the only national nonprofit healthcare organization focusing 100 percent of its resources and attention on stroke. In its brief history, National Stroke Association has become a leading national resource on stroke and the driving force behind efforts to improve stroke prevention, treatment, rehabilitation and support for all impacted by stroke. Learn more at: http://www.nationalstrokeassociation.com.

About CureLauncher:
CureLauncher gives people the power and support to make a life-changing decision. Its patent-pending matching system helps people find treatment options that are aligned with their unique goals and conditions. Take Control. Know Your Options™. Learn more at http://www.CureLauncher.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10954941.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
3. International Attendance for Networking and Education at Informex Beyond Manufacturing
4. Sundberg Kicks Off National Expansion With Openings of New Headquarters, Logistically Centric Mega Warehouses
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
9. PAREXEL International to Present at J.P. Morgan Healthcare Conference
10. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
11. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The Blavatnik ... Winners and six Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. ... Foundation and administered by the New York Academy of Sciences to honor the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology:
(Date:6/30/2017)... , June 30, 2017 Today, ... developer and supplier of face and eye tracking ... Featured Product provider program. "Artificial ... innovative way to monitor a driver,s attentiveness levels ... from being able to detect fatigue and prevent ...
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
(Date:5/16/2017)...  Veratad Technologies, LLC ( www.veratad.com ), an innovative ... verification solutions, announced today they will participate as a ... thru May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions ... evolving digital world, defining identity is critical to nearly ...
Breaking Biology News(10 mins):